RE: Covid Treatment - Approved4 Nov 2021 12:07
It goes like this.
With winter approaching and
hospitalisation rates rising, the UK MHRA has rushed through the approval of Merck's Molnupiravir
(LAGEVRIO) and the UK Government has already secured 480,000 courses of treatment. The UK is
the first country to have approved the drug, with a US FDA panel expected to meet on November
30th to discuss the safety and efficacy data. One major concern from scientists in the US has been
data from the University of Chapel Hill in North Carolina that the drug induces mutations in
mammalian cells, which is less than ideal for a treatment that requires 40 pills in a course.